Wall Street Experts
ver. ZuMIgo(08/25)
GoodRx Holdings, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 790
EBIT TTM (mln): 51
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
| Rok finansowy |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
99 |
157 |
250 |
388 |
551 |
745 |
767 |
750 |
792 |
| Przychód Δ r/r |
0.0% |
58.2% |
58.7% |
55.6% |
41.9% |
35.4% |
2.8% |
-2.1% |
5.6% |
| Marża brutto |
89.6% |
92.3% |
97.6% |
96.4% |
94.6% |
93.7% |
91.5% |
77.3% |
93.9% |
| EBIT (mln) |
19 |
50 |
77 |
140 |
-276 |
13 |
11 |
51 |
66 |
| EBIT Δ r/r |
0.0% |
165.9% |
53.6% |
80.8% |
-297.4% |
-104.9% |
-17.9% |
366.5% |
28.2% |
| EBIT (%) |
19.0% |
32.0% |
31.0% |
36.0% |
-50.1% |
1.8% |
1.4% |
6.8% |
8.3% |
| Koszty finansowe (mln) |
4 |
7 |
22 |
50 |
28 |
24 |
34 |
57 |
53 |
| EBITDA (mln) |
28 |
59 |
87 |
151 |
-257 |
48 |
65 |
163 |
154 |
| EBITDA(%) |
28.2% |
37.8% |
34.9% |
38.9% |
-46.7% |
6.4% |
8.5% |
21.7% |
19.4% |
| Podatek (mln) |
6 |
11 |
9 |
17 |
-10 |
15 |
10 |
-47 |
15 |
| Zysk Netto (mln) |
-8 |
9 |
44 |
66 |
-294 |
-25 |
-33 |
-9 |
16 |
| Zysk netto Δ r/r |
0.0% |
-213.8% |
395.2% |
50.8% |
-544.6% |
-91.4% |
30.0% |
-73.0% |
-284.8% |
| Zysk netto (%) |
-7.8% |
5.6% |
17.6% |
17.0% |
-53.3% |
-3.4% |
-4.3% |
-1.2% |
2.1% |
| EPS |
-0.0202 |
0.0229 |
0.12 |
0.11 |
-0.75 |
-0.063 |
-0.0795 |
-0.0216 |
0.12 |
| EPS (rozwodnione) |
-0.0202 |
0.0229 |
0.12 |
0.11 |
-0.75 |
-0.063 |
-0.0795 |
-0.0216 |
0.12 |
| Ilośc akcji (mln) |
385 |
385 |
356 |
385 |
392 |
401 |
413 |
410 |
386 |
| Ważona ilośc akcji (mln) |
385 |
385 |
363 |
385 |
392 |
401 |
413 |
410 |
392 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |